
Right now, wouldn’t it be good if we had a simple and cheap way to test for coronavirus?
The rise in the share value of several pharmaceutical companies working on research and developing products in the fight against the SARS CoV-2 epidemic, the latest being Spain’s Pharmamar, highlights the importance of reliable and rapid diagnostic tests in containing an epidemic.